Robert Spurr - Feb 15, 2022 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Role
U.S. President-Pharma Business
Signature
/s/ Debra E. Levin, attorney-in-fact
Stock symbol
BHC
Transactions as of
Feb 15, 2022
Transactions value $
-$81,340
Form type
4
Date filed
2/17/2022, 03:36 PM
Previous filing
Jan 20, 2022
Next filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHC Common Shares, No Par Value Sale -$81.3K -3.25K -5.12% $25.02 60.3K Feb 15, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2021.